Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Cary C who wrote (9289)	7/14/2005 10:03:55 AM
From: Galirayo	Read Replies (1) \| Respond to of 23958

LOL .. Why Not ?? .. I can't Multi Task ... We need someone that can. lmao

To: Cary C who wrote (9289)	7/14/2005 10:13:23 AM
From: Sergio H	Read Replies (1) \| Respond to of 23958

I'm glad Ken explained the ALAN warrants. The math escaped me too. Cary, I've taken a small position in PUMP. This company is number two in insulin pumps. Medtronic has between 75% and 80% of market share and there's really nobody else. Roche Labs was banned and is on tap to re-enter the market late this year. Meanwhile, PUMP has established a niche and is growing nicely. I think that once it becomes cash flow positive it becomes a take over for a larger player with an interest in entry into the diabetes device arena.